Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures  Text with EEA relevance
Date: 2013-10-02
Institutions: European Commission
Subjects: chemical product, classification, dangerous substance, environmental impact, health risk, labelling, packaging, technological change




L_2013261EN.01000501.xml










3.10.2013   


EN


Official Journal of the European Union


L 261/5








            COMMISSION REGULATION (EU) No 944/2013
of 2 October 2013
         
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) and Article 53 thereof,

Whereas:







(1)


In respect of precautionary statement P210 set out in table 6.2 Part 1 of Annex IV to Regulation (EC) No 1272/2008 the 5th revision of the Globally Harmonised System of Classification and Labelling of Chemicals (hereinafter ‘GHS’) of the United Nations has brought about changes which were not fully taken into account in Commission Regulation (EU) No 487/2013 (2). For reasons of consistency it is necessary to provide for full alignment between the GHS and Regulation (EC) No 1272/2008.












(2)


Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (3). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications.












(3)


The Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances.












(4)


The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (4).












(5)


With regard to the substance pitch, coal tar, high-temp. (EC Number: 266-028-2), an extended period of time will be necessary to allow operators to comply with the obligations resulting from the new harmonised classification for substances classified as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 3 and Annex III of Directive 2008/68/EC of the European Parliament and of the Council of 24 September 2008 on the inland transport of dangerous goods (5). Therefore, a longer transition time should be foreseen before the harmonised classification has to be applied.












(6)


With regard to the substance gallium arsenide (EC Number: 215-114-8), the RAC is in the process of adopting a new opinion for the hazard class ‘toxicity to reproduction’. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that opinion is finalised.












(7)


With regard to the substance polyhexamethylene biguanide hydrochloride (CAS number 27083-27-8 or 32289-58-0), new scientific data has been made available for the hazard class ‘acute toxicity (inhalation)’, which suggests that the classification for this hazard class as recommended in the RAC opinion, which is based on older data, might not be appropriate. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has had the opportunity to deliver an opinion on the new information, while all other hazard classes covered by the earlier RAC opinion should be included.












(8)


In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before the dates by which the harmonised classifications will become mandatory.












(9)


The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,





HAS ADOPTED THIS REGULATION:



Article 1
Regulation (EC) No 1272/2008 is amended as follows:






(1)


Annex IV is amended in accordance with the Annex I to this Regulation;










(2)


Part 3 of Annex VI is amended as follows:






(a)


Table 3.1 is amended as follows:






(i)


The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex II to this Regulation are replaced by the entries set out in Annex II to this Regulation;










(ii)


The entries set out in Annex III to this Regulation are inserted in accordance with the order of the entries set out in Table 3.1.














(b)


Table 3.2 is amended as follows:






(i)


The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex IV to this Regulation are replaced by the entries set out in in Annex IV to this Regulation;










(ii)


The entries set out in Annex V to this Regulation are inserted in accordance with the order of the entries set out in Table 3.2.














Article 2

1.   By way of derogation from Article 3(2) substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation.


2.   By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 December 2016.


3.   By way of derogation from Article 3(2) mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council (6) or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 June 2017.


4.   By way of derogation from Article 3(3) the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, may be applied before the dates referred to in Article 3(3).



Article 3

1.   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.


2.   Article 1(1) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.


3.   Article 1(2) shall apply from 1 January 2015 for all entries except for the entry pitch, coal tar, high-temp. (EC Number 266-028-2), for which Article 1 shall apply from 1 April 2016.





This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 2 October 2013.


For the Commission


The President

José Manuel BARROSO
            





(1)  
            OJ L 353, 31.12.2008, p. 1.

(2)  
            OJ L 149, 1.6.2013, p. 1.

(3)  
            OJ 196, 16.8.1967, p. 1.

(4)  
            OJ L 396, 30.12.2006, p. 1.

(5)  
            OJ L 260, 30.9.2008, p. 13.

(6)  
            OJ L 200, 30.7.1999, p. 1.




ANNEX I
In Part 1, Table 6.2 of Annex IV to Regulation (EC) No 1272/2008, Code P210 is replaced by the following:










‘P210


Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.


Explosives (section 2.1)


Divisions 1.1, 1.2, 1.3, 1.4, 1.5


 




Flammable gases (section 2.2)


1, 2




Aerosols (section 2.3)


1, 2, 3




Flammable liquids (section 2.6)


1, 2, 3




Flammable solids (section 2.7)


1, 2




Self-reactive substances and mixtures (section 2.8)


Types A, B, C, D, E, F




Pyrophoric liquids (section 2.9)


1




Pyrophoric solids (section 2.10)


1




Oxidising liquids (section 2.13)


1, 2, 3




Oxidising solids (section 2.14)


1, 2, 3




Organic peroxides (section 2.15)


Types A, B, C, D, E, F’










ANNEX II















Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Specific Conc. Limits,
M — Factors


Notes




Hazard Class and Category Code(s)


Hazard statement Code(s)


Pictogram, Signal Word Code(s)


Hazard statement Code(s)


Suppl. Hazard statement Code(s)




015-004-00-8


aluminium phosphide


244-088-0


20859-73-8


Water-react. 1


H260


GHS02


H260


EUH029


M = 100


 




Acute Tox. 2


H300


GHS06


H300


EUH032


 




Acute Tox. 3


H311


GHS09


H311


 




Acute Tox. 1


H330


Dgr


H330


 




Aquatic Acute 1


H400


 


H400


 




015-005-00-3


magnesium phosphide;
trimagnesium diphosphide


235-023-7


12057-74-8


Water-react. 1


H260


GHS02


H260


EUH029


M = 100


 




Acute Tox. 2


H300


GHS06


H300


EUH032


 




Acute Tox. 3


H311


GHS09


H311


 




Acute Tox. 1


H330


Dgr


H330


 




Aquatic Acute 1


H400


 


H400


 




015-123-00-5


fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate


244-848-1


22224-92-6


Acute Tox. 2


H300


GHS06


H300


 


M = 100
M = 100


 




Acute Tox. 2


H310


GHS09


H310




Acute Tox. 2


H330


Dgr


H330




Eye Irrit. 2


H319


 


H319




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




030-012-00-1


aluminium-magnesium-zinc-carbonate-hydroxide


423-570-6


169314-88-9


Aquatic Chronic 4


H413


 


H413


 


 


 




602-006-00-4


chloroform;
trichloromethane


200-663-8


67-66-3


Carc. 2


H351


GHS06


H351


 


 


 




Repr. 2


H361d


GHS08


H361d




Acute Tox. 3


H331


Dgr


H331




Acute Tox. 4


H302


 


H302




STOT RE 1


H372


 


H372




Eye Irrit. 2


H319


 


H319




Skin Irrit. 2


H315


 


H315




603-097-00-3


1,1’,1’-nitrilotripropan-2-ol;
triisopropanolamine


204-528-4


122-20-3


Eye Irrit. 2


H319


GHS07
Wng


H319


 


 


 




605-008-00-3


acrolein;
prop-2-enal;
acrylaldehyde


203-453-4


107-02-8


Flam. Liq. 2


H225


GHS02


H225


EUH071


Skin Corr. 1; H314: C ≥ 0,1 %


D




Acute Tox. 1


H330


GHS06


H330


 




Acute Tox. 2


H300


GHS05


H300


 




Acute Tox. 3


H311


GHS09


H311


 




Skin Corr. 1


H314


Dgr


H314


 




Aquatic Acute 1


H400


 


 


 


M = 100




Aquatic Chronic 1


H410


 


H410


 


M = 1




607-023-00-0


vinyl acetate


203-545-4


108-05-4


Flam. Liq. 2


H225


GHS02


H225


 


 


D




Carc. 2


H351


GHS08


H351


 


 




Acute Tox. 4


H332


GHS07


H332


 


 




STOT SE 3


H335


Dgr


H335


 


 




607-613-00-8


reaction mass of:






 


succinic acid










 


monopersuccinic acid










 


dipersuccinic acid










 


monomethyl ester of succinic acid










 


monomethyl ester of persuccinic acid










 


dimethyl succinate glutaric acid










 


monoperglutaric acid










 


diperglutaric acid










 


monomethyl ester of glutaric acid










 


monomethyl ester of perglutaric acid










 


dimethyl glutarate adipic acid










 


monoperadipic acid










 


diperadipic acid










 


monomethyl ester of adipic acid










 


monomethyl ester of peradipic acid










 


dimethyl adipate










 


hydrogen peroxide










 


methanol










 


water






432-790-1


 


Acute Tox. 4*


H332


GHS07


H332


 


 


 




Acute Tox. 4*


H312


GHS05


H312




Acute Tox. 4*


H302


GHS08


H302




Skin Corr. 1B


H314


Dgr


H314




STOT SE 2


H371 (eyes)


 


H371 (eyes)




609-003-00-7


nitrobenzene


202-716-0


98-95-3


Carc. 2.


H351


GHS06


H351


 


 


 




Repr. 1B


H360F


GHS08


H360F




Acute Tox. 3


H301


Dgr


H301




Acute Tox. 3


H331


 


H331




Acute Tox. 3


H311


 


H311




STOT RE 1


H372 (blood)


 


H372 (blood)




Aquatic Chronic 3


H412


 


H412




612-120-00-6


aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline


277-704-1


74070-46-5


Carc. 2


H351


GHS08


H351


 


M = 100
M = 10


 




Skin Sens. 1A


H317


GHS07


H317


 




Aquatic Acute 1


H400


GHS09


 


 




Aquatic Chronic 1


H410


Wng


H410


 




613-175-00-9


epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane


406-850-2


133855-98-8


Carc. 2


H351


GHS08


H351


 


 


 




Repr. 1B


H360Df


GHS09


H360Df




Aquatic Chronic 2


H411


Dgr


H411




616-200-00-1


reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)


432-430-3


 


Aquatic Chronic 4


H413


 


H413


 


 


 




648-055-00-5


pitch, coal tar, high-temp.;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]


266-028-2


65996-93-2


Carc. 1A


H350


GHS08


H350


 


M = 1000
M = 1000


 




Muta. 1B


H340


GHS09


H340


 




Repr. 1B


H360FD


Dgr


H360FD


 




Aquatic Acute 1


H400


 


 


 




Aquatic Chronic 1


H410


 


H410


 




649-330-00-2


naphtha (petroleum), hydrodesulphurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]


265-185-4


64742-82-1


Carc. 1B


H350


GHS08


H350


 


 


P




Muta. 1B


H340


Dgr


H340




STOT RE 1


H372 (central nervous system)


 


H372 (central nervous system)




Asp. Tox. 1


H304


 


H304




649-345-00-4


stoddard solvent;
Low boiling point naphtha — unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]


232-489-3


8052-41-3


Carc. 1B


H350


GHS08


H350


 


 


P




Muta. 1B


H340


Dgr


H340




STOT RE 1


H372 (central nervous system)


 


H372 (central nervous system)




Asp. Tox. 1


H304


 


H304




649-405-00-X


solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]


265-191-7


64742-88-7


STOT RE 1


H372 (central nervous system)


GHS08


H372 (central nervous system)


 


 


 




Asp. Tox. 1


H304


Dgr


H304









ANNEX III















Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Specific Conc. Limits,
M — Factors


Notes




Hazard Class and Category Code(s)


Hazard statement Code(s)


Pictogram, Signal Word Code(s)


Hazard statement Code(s)


Suppl. Hazard statement Code(s)




031-001-00-4


gallium arsenide


215-114-8


1303-00-0


Carc. 1B


H350


GHS08


H350


 


 


 




STOT RE 1


H372 (respiratory and haematopoietic systems)


Dgr


H372 (respiratory and haematopoietic systems)




050-025-00-6


trichloromethylstannane


213-608-8


993-16-8


Repr. 2


H361d


GHS08
Wng


H361d


 


 


 




050-026-00-1


2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate


260-828-5


57583-34-3


Repr. 2


H361d


GHS08
Wng


H361d


 


 


 




050-027-00-7


2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate


239-622-4


15571-58-1


Repr. 1B


H360D


GHS08
Dgr


H360D


 


 


 




601-087-00-3


2,4,4-trimethylpentene


246-690-9


25167-70-8


Flam. Liq. 2


H225


GHS02


H225


 


 


D




Asp. Tox. 1


H304


GHS07


H304




STOT SE 3


H336


GHS08
Dgr


H336




606-145-00-1


sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione


 


99105-77-8


Repr. 2


H361d


GHS08


H361d


 


M = 1
M = 10


 




STOT RE 2


H373 (kidneys)


GHS07


H373 (kidneys)




Skin Sens. 1A


H317


GHS09


H317




Aquatic Acute 1


H400


Wng


 




Aquatic Chronic 1


H410


 


H410




607-699-00-7


bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate


 


82657-04-3


Carc. 2


H351


GHS06


H351


 


M = 10 000 
M = 100 000 


 




Acute Tox. 3


H331


GHS08


H331




Acute Tox. 2


H300


GHS09


H300




STOT RE 1


H372 (nervous system)


Dgr


H372 (nervous system)




Skin Sens. 1B


H317


 


H317




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




607-700-00-0


indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]


 


173584-44-6 [1]


Acute Tox. 3


H301


GHS06


H301


 


M = 1
M = 1


 




Acute Tox. 4


H332


GHS08


H332




STOT RE 1


H372 (blood, nervous system, heart)


GHS09


H372 (blood, nervous system, heart)




Skin Sens. 1B


H317


Dgr


H317




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]


144171-61-9 [2]


 


 


 


 




607-702-00-1


dihexyl phthalate


201-559-5


84-75-3


Repr. 1B


H360FD


GHS08
Dgr


H360FD


 


 


 




607-703-00-7


ammoniumpentadeca- fluorooctanoate


223-320-4


3825-26-1


Carc. 2


H351


GHS08


H351


 


 


 




Repr. 1B


H360D


GHS07


H360D




Lact.


H362


GHS05


H362




Acute Tox. 4


H332


Dgr


H332




Acute Tox. 4


H302


 


H302




STOT RE 1


H372 (liver)


 


H372 (liver)




Eye Dam.1


H318


 


H318




607-704-00-2


perfluorooctanoic acid


206-397-9


335-67-1


Carc. 2


H351


GHS08


H351


 


 


 




Repr. 1B


H360D


GHS07


H360D




Lact.


H362


GHS05


H362




Acute Tox. 4


H332


Dgr


H332




Acute Tox. 4


H302


 


H302




STOT RE 1


H372 (liver)


 


H372 (liver)




Eye Dam. 1


H318


 


H318




612-282-00-8


octadecylamine


204-695-3


124-30-1


Asp. Tox. 1


H304


GHS05


H304


 


M = 10
M = 10


 




STOT RE 2


H373 (gastro-intestinal tract, liver, immune system)


GHS08


H373 (gastro-intestinal tract, liver, immune system)




Skin Irrit. 2


H315


GHS09


H315




Eye Dam. 1


H318


Dgr


H318




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




612-283-00-3


(Z)-octadec-9-enylamine


204-015-5


112-90-3


Acute Tox. 4


H302


GHS05


H302


 


M = 10
M = 10


 




Asp Tox. 1


H304


GHS07


H304




STOT SE 3


H335


GHS08


H335




STOT RE 2


H373 (gastro-intestinal tract, liver, immune system)


GHS09


H373 (gastro-intestinal tract, liver, immune system)




Skin Corr. 1B


H314


Dgr


H314




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




612-284-00-9


amines, hydrogenated tallow alkyl


262-976-6


61788-45-2


Asp Tox. 1


H304


GHS08


H304


 


M = 10
M = 10


 




STOT RE 2


H373 (gastro-intestinal tract, liver, immune system)


GHS05


H373 (gastro-intestinal tract, liver, immune system)




Skin Irrit. 2


H315


GHS09


H315




Eye Dam. 1


H318


Dgr


H318




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




612-285-00-4


amines, coco alkyl


262-977-1


61788-46-3


Acute Tox. 4


H302


GHS05


H302


 


M = 10
M = 10


 




Asp. Tox. 1


H304


GHS07


H304




STOT SE 3


H335


GHS08


H335




STOT RE 2


H373 (gastro-intestinal tract, liver, immune system)


GHS09


H373 (gastro-intestinal tract, liver, immune system)




Skin Corr. 1B


H314


Dgr


H314




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




612-286-00-X


amines, tallow alkyl


263-125-1


61790-33-8


Acute Tox. 4


H302


GHS05


H302


 


M = 10
M = 10


 




Asp. Tox. 1


H304


GHS07


H304




STOT RE 2


H373 (gastro-intestinal tract, liver, immune system)


GHS08


H373 (gastro-intestinal tract, liver, immune system)




Skin Corr. 1B


H314


GHS09


H314




Aquatic Acute 1


H400


Dgr


 




Aquatic Chronic 1


H410


 


H410




616-206-00-4


flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea


417-680-3


101463-69-8


Lact.


H362


GHS09


H362


 


M = 10 000 
M = 10 000 


 




Aquatic Acute 1


H400


Wng


 




Aquatic Chronic 1


H410


 


H410




616-207-00-X


polyhexamethylene biguanide hydrochloride


 


27083-27-8 or 32289-58-0


Carc. 2


H351


GHS05


H351


 


M = 10
M = 10


 




Acute Tox. 4


H302


GHS07


H302




STOT RE 1


H372 (respiratory tract) (inhalation)


GHS08


H372 (respiratory tract) (inhalation)




Eye Dam. 1


H318


GHS09


H318




Skin Sens. 1B


H317


Dgr


H317




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




616-208-00-5


N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one


220-250-6


2687-91-4


Repr. 1B


H360D


GHS08
Dgr


H360D


 


 


 




616-209-00-0


amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea


407-380-0


120923-37-7


Aquatic Acute 1


H400


GHS09


 


 


M = 100
M = 100


 




Aquatic Chronic 1


H410


Wng


H410




616-210-00-6


tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide


 


119168-77-3


Acute Tox. 3


H301


GHS06


H301


 


M = 10
M = 10


 




Acute Tox. 4


H332


GHS08


H332




STOT RE 2


H373 (gastro-intestinal tract) (Oral)


GHS09


H373 (gastro-intestinal tract) (Oral)




Skin Sens. 1B


H317


Dgr


H317




Aquatic Acute 1


H400


 


 




Aquatic Chronic 1


H410


 


H410




616-211-00-1


proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one


 


189278-12-4


Carc. 2


H351


GHS08


H351


 


M = 1
M = 10


 




Aquatic Acute 1


H400


GHS09


 




Aquatic Chronic 1


H410


Wng


H410









ANNEX IV












Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Concentration Limits


Notes




015-004-00-8


aluminium phosphide


244-088-0


20859-73-8


F; R15/29
T+; R26/28
Xn; R21
R32
N; R50


F; T+; N
R: 15/29-21-26/28-32-50
S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61


N; R50: C ≥ 0,25 %


 




015-005-00-3


magnesium phosphide;
trimagnesium diphosphide


235-023-7


12057-74-8


F; R15/29
T+; R26/28
Xn; R21
R32
N; R50


F; T+; N
R: 15/29-21-26/28-32-50
S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61


N; R50: C ≥ 0,25 %


 




015-123-00-5


fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate


244-848-1


22224-92-6


T+; R26/28
T; R24
Xi; R36
N; R50-53


T+; N
R: 24-26/28-36-50/53
S: (1/2-)23-26-28-35-36/37-45-60-61


N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


 




030-012-00-1


aluminium-magnesium-zinc-carbonate-hydroxide


423-570-6


169314-88-9


R53


R: 53
S: 61


 


 




602-006-00-4


chloroform;
trichloromethane


200-663-8


67-66-3


Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R20/22-48/20
Xi; R36/38


Xn
R: 20/22-36/38-40-48/20-63
S: (2-)36/37


 


 




603-097-00-3


1,1′,1′′-nitrilotripropan-2-ol;
triisopropanolamine


204-528-4


122-20-3


Xi; R36


Xi
R: 36
S: (2-)26


 


 




605-008-00-3


acrolein;
prop-2-enal;
acrylaldehyde


203-453-4


107-02-8


F; R11
T+; R26/28
T; R24
C; R34
N; R50


F; T+; N
R: 11-24-26/28-34-50
S: (1/2-)23-26-28-36/37/39-45-61


C; R34: C ≥ 0,1 %
N; R50: C ≥ 0,25 %


D




607-023-00-0


vinyl acetate


203-545-4


108-05-4


F; R11
Carc. Cat. 3; R40
Xn; R20
Xi; R37


F; Xn
R: 11-20-37-40
S: 9-16-33-36/37


 


D




607-613-00-8


reaction mass of:






 


succinic acid










 


monopersuccinic acid










 


dipersuccinic acid










 


monomethyl ester of succinic acid










 


monomethyl ester of persuccinic acid










 


dimethyl succinate










 


glutaric acid










 


monoperglutaric acid










 


diperglutaric acid










 


monomethyl ester of glutaric acid










 


monomethyl ester of perglutaric acid










 


dimethyl glutarate










 


adipic acid










 


monoperadipic acid










 


diperadipic acid










 


monomethyl ester of adipic acid










 


monomethyl ester of peradipic acid










 


dimethyl adipate










 


hydrogen peroxide










 


methanol










 


water






432-790-1


 


C; R34
Xn; R20/21/22-68/20/21/22


C
R: 20/21/22-34-68/20/21/22
S: (1/2-)26-28-36/37/39-45


 


 




609-003-00-7


nitrobenzene


202-716-0


98-95-3


Carc. Cat. 3; R40
Repr. Cat. 2; R60
T; R23/24/25-48/23/24/25
R52-53


T
R: 23/24/25-48/23/24/25-40-60-52/53
S: 45-53


 


 




612-120-00-6


aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline


277-704-1


74070-46-5


Carc. Cat. 3; R40
R43
N; R50-53


Xn; N
R: 40-43-50/53
S: (2-)36/37-60-61


R43: C ≥ 0,1 %
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


 




613-175-00-9


epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane


406-850-2


133855-98-8


Carc. Cat. 3; R40
Repr. Cat. 2; R61
Repr. Cat. 3; R62
N; R51-53


T; N
R: 61-40-62-51/53
S: 45-53-61


 


 




616-200-00-1


reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)


432-430-3


 


R53


R: 53
S: 61


 


 




648-055-00-5


pitch, coal tar, high-temp.;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]


266-028-2


65996-93-2


Carc. Cat. 1; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
N; R50-53


T; N
R: 45-46-60-61-50/53
S: 45-53-60-61


N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C <
0,025  %
R52-53: 0,00025 % ≤ C <
0,0025  %


 




649-330-00-2


naphtha (petroleum), hydrodesulphurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]


265-185-4


64742-82-1


Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/20-65


T
R: 45-46-48/20-65
S: 45-53


 


P




649-345-00-4


stoddard solvent;
Low boiling point naphtha — unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]


232-489-3


8052-41-3


Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/20-65


T
R: 45-46-48/20-65
S: 45-53


 


P




649-405-00-X


solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]


265-191-7


64742-88-7


Xn; R48/20-65


Xn
R: 48/20-65
S: (2-)23-24-62


 


 









ANNEX V












Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Concentration Limits


Notes




031-001-00-4


gallium arsenide


215-114-8


1303-00-0


Carc. Cat. 2; R45
T; R48/23


T
R: 45-48/23
S: 45-53


 


E




050-025-00-6


trichloromethylstannane


213-608-8


993-16-8


Repr. Cat. 3; R63


Xn
R: 63
S: (2-)22-36/37


 


 




050-026-00-1


2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate


260-828-5


57583-34-3


Repr. Cat. 3; R63


Xn
R: 63
S: (2-)22-36/37


 


 




050-027-00-7


2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate


239-622-4


15571-58-1


Repr. Cat. 2; R61


T
R: 61
S: 45-53


 


 




601-087-00-3


2,4,4-trimethylpentene


246-690-9


25167-70-8


F; R11
Xn; R65
R67


F; Xn
R: 11-65-67
S: 9-16-33-62


 


D




606-145-00-1


sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione


 


99105-77-8


Repr. Cat. 3; R63
Xn; R48/22
R43
N; R50-53


Xn; N
R: 43-48/22-63-50/53
S: (2-)22-36/37-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C< 2,5 %
R43: C ≥ 0,1 %


 




607-699-00-7


bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate


 


82657-04-3


Carc. Cat 3; R40
T; R23/25
Xn; R48/22
R43
N; R50-53


T; N
R: 23/25-40-43-48/22-50/53
S: (1/2-)23-24-36/37-38- 45-60-61


N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C< 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %


 




607-700-00-0


indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate


 


173584-44-6


T; R25-48/25
Xn; R20
R43
N; R50-53


T; N
R: 20-25-43-48/25-50/53
S: (1/2-)24-37-45-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




607-701-00-6


reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate


 


144171-61-9


T; R48/25
Xn; R20/22
R43
N; R50-53


T; N
R: 20/22-43-48/25-50/53
S: (1/2-)24-37-45-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




607-702-00-1


dihexyl phthalate


201-559-5


84-75-3


Repr. Cat. 2; R60-61


T
R: 60-61
S: 45-53


 


 




607-703-00-7


ammoniumpentade-cafluorooctanoate


223-320-4


3825-26-1


Carc. Cat. 3; R40
Repr. Cat. 2; R61
R64
T; R48/23
Xn; R20/22-48/21/22
Xi; R41


T
R: 61-20/22-40-41- 48/23-48/21/22-64
S: 45-53


 


 




607-704-00-2


perfluorooctanoic acid


206-397-9


335-67-1


Carc. Cat. 3; R40
Repr. Cat. 2; R61
R64
T; R48/23
Xn; R20/22-48/21/22
Xi; R41


T
R: 61-20/22-40-41-48/23-48/21/22-64
S: 45-53


 


 




612-282-00-8


octadecylamine


204-695-3


124-30-1


Xn; R48/22-65
Xi; R38-41
N; R50-53


Xn; N
R: 38-41-48/22-65-50/53
S: (2-)26-36/37/39-60-61-62


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




612-283-00-3


(Z)-octadec-9-enylamine


204-015-5


112-90-3


Xn; R22-48/22-65
C; R34
N; R50-53


C; N
R: 22-34-48/22-65-50/53
S: (1/2-)23-26-36/37/39-45-60-61-62


C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




612-284-00-9


amines, hydrogenated tallow alkyl


262-976-6


61788-45-2


Xn; R48/22-65
Xi; R38-41
N; R50-53


Xn; N
R: 38-41-48/22-65-50/53
S: (2-)26-36/37/39-60-61-62


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




612-285-00-4


amines, coco alkyl


262-977-1


61788-46-3


Xn; R22-48/22-65
C; R35
N; R50-53


C; N
R: 22-35-48/22-65-50/53
S: (1/2-)23-26-36/37/39-45-60-61-62


C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




612-286-00-X


amines, tallow alkyl


263-125-1


61790-33-8


Xn; R22-48/22-65
C; R35
N; 50-53


C; N
R: 22-35-48/22-65-50/53
S: (1/2-)26-36/37/39-45-60-61-62


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




616-206-00-4


flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea


417-680-3


101463-69-8


R64
R33
N; R50-53


N
R: 33-64-50/53
S: (2-)22-36/37-46-60-61


N; R50-53 C ≥ 0,0025 %
N; R51-53 0,00025 % ≤ C < 0,0025 %
R52-53 0,000025 % ≤ C < 0,00025 %


 




616-207-00-X


polyhexamethylene biguanide hydrochloride


 


27083-27-8 or 32289-58-0


Carc. Cat 3; R40
Xn; R22
T; R48/23
Xi; R41
R43
N; R50-53


T; N
R: 22-40-41-43-48/23-50/53
S: (1/2-)22-36/37/39-45-60-61


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




616-208-00-5


N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one


220-250-6


2687-91-4


Repr. Cat. 2; R61


T
R: 61
S: 45-53


 


 




616-209-00-0


amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea


407-380-0


120923-37-7


N; R50-53


N
R: 50/53
S: 60-61


N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


 




616-210-00-6


tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-carboxamide


 


119168-77-3


Xn; R20/22
R43
N; R50-53


Xn; N
R: 20/22-43-50/53
S: (2-)24-37-46-60-61


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




616-211-00-1


proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one


 


189278-12-4


Carc. Cat. 3; R40
N; R50-53


Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61